For instance, Goodwin et al. (2008) found that both tumor and matched normal tissues from prostate cancer patients exhibit significantly higher expression of spermine oxidase [41], which has been linked to increased ROS and DNA damage [42], [43], versus tissues from prostate disease-free patients. This evidence concerns the gene SMOX and prostate cancer.